New insights into prevention of donor-specific corneal graft rejection

Cornea

Volumn 19, Issue 6 SUPPL. 3, 2000, Pages

  Yamada, J ^a   Streilein, J W ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Corneal transplantation; Delayed hypersensitivity; Immune privilege; Indirect pathway of allorecognition; T helper type 1 cells

Indexed keywords

MINOR HISTOCOMPATIBILITY ANTIGEN;

ALLOGRAFT; ALLOIMMUNITY; ANTIGEN RECOGNITION; CONFERENCE PAPER; CORNEA TRANSPLANTATION; GRAFT REJECTION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033733183     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200000003-00008     Document Type: Conference Paper

References (62)

1. The influence of donor-recipient sensitization on corneal grafts
2. Penetrating corneal transplantation in the inbred rat: A new model
3. Orthotopic corneal transplantation in mice - Evidence that the immunogenetic rules of rejection do not apply
4. The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation
5. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye
6. The immune privilege of corneal allografts
7. Corneal transplantation - Immunologically privileged status
8. Fas ligand-induced apoptosis as a mechanism of immune privilege
9. Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts
10. The high-risk penetrating keratoplasty
11. Immunosuppressive properties of tissues obtained from eyes with experimentally manipulated corneas
12. Graft failure after penetrating keratoplasty
13. Corticosteroids in corneal graft rejection. Oral versus single pulse therapy
14. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies
15. Corticosteroid therapy of eye disease. Fifty years later
16. Immunosuppressive drugs in immune and inflammatory ocular disease
17. Immunosuppressive agents in penetrating keratoplasty
18. Steroids
19. Fate of orthotopic corneal allografts in C57BL/6 mice
20. Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice
21. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice
22. Corneal allografts fail to express Ia antigens
23. Langerhans cells of the ocular surface
24. The expression of HLA antigens by cells in the human cornea
25. The distribution and ontogeny of MHC antigens in murine ocular tissue
26. The distribution of HLA antigens on human corneal tissue
27. Interleukin-1 receptor antagonist suppresses allosensitization in corneal transplantation
28. Indirect presentation of MHC antigens in transplantation
29. + T-cell dependent antibody-mediated graft rejection
30. Mechanisms of T cell recognition of alloantigen. The role of peptides
31. Detection of minor alloantigen-specific cytotoxic T cells after rejection of murine orthotopic corneal allografts: Evidence that graft antigens are recognized exclusively via the 'indirect pathway.'
32. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens
33. Phagocytosis of particulate antigens by corneal epithelial cells stimulates interleukin-1 secretion and migration of Langerhans cells into the central cornea
34. Effect of cytokine-induced migration of Langerhans cells on corneal allograft survival
35. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells
36. Topical interleukin 1 receptor antagonist promotes corneal transplant survival
37. Cellular and humoral anticorneal immune response in corneal transplantation
38. The humoral response to an allograft
39. Humoral immunity to heterotopic corneal allografts in the rat
40. The association of lymphocytotoxic antibodies with corneal allograft rejection in high risk patients. The Collaborative Corneal Transplantation Studies Research Group
41. Antibody and cell mediated immune responses during rejection of a murine orthotopic corneal graft
42. Corneal transplantation in antibody-deficient hosts
43. The cellular basis of allograft rejection in vivo. III. Restoration of first-set rejection of heart grafts by T helper cells in irradiated rats
44. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection
45. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody
46. Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody
47. + T cells in immunobiology of orthotopic corneal transplants in mice
48. T-cell mediated responses in a murine model of orthotopic corneal transplantation
49. Role of donor-specific cytotoxic T cells in rejection of corneal allografts in normal and high-risk eyes
50. Cytotoxic T cells play no essential role in rejection of orthotopic corneal allografts in mice
51. The effect of oral immunization on corneal allograft survival
52. Oral immunisation as a strategy for enhancing corneal allograft survival
53. Immunologic phenotype of hosts orally immunized with corneal alloantigens
54. Induction of donor-specific ACAID can prolong orthotopic corneal allograft survival in 'high-risk' eyes
55. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts
56. Ability of intracamerally inoculated B- and T-cell enriched allogeneic lymphocytes to enhance corneal allograft survival
57. Induction of anterior chamber-associated immune deviation with lymphoreticular allogeneic cells
58. Anterior chamber-associated immune deviation promotes corneal allograft survival
59. Intracameral injection of allogeneic lymphocytes enhances corneal graft survival
60. Lymphocyte responses and cytokines
61. Polarization of Th-cell responses: A phylogenetic consequence of nonspecific immune defence?
62. Mice with Th2-biased immune systems accept orthotopic corneal allografts placed in 'high risk' eyes